About this FactMed analysis covering adverse side effect reports of ALIZAPRIDE patients who developed ENTERITIS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 3 individuals taking ALIZAPRIDE reported ENTERITIS to the FDA. A total of 102 ALIZAPRIDE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALIZAPRIDE and ENTERITIS. In doing so, we compare ALIZAPRIDE with other drugs that cause ENTERITIS, to help you evaluate whether or not ALIZAPRIDE causes ENTERITIS. Likewise, this page shows the most highly-reported side effects of ALIZAPRIDE, so you can see if ENTERITIS ranks among ALIZAPRIDE's most well-known side effects.
Summary Statistics
Reports of ALIZAPRIDE causing ENTERITIS: 3
Reports of any side effect of ALIZAPRIDE : 102
Percentage of ALIZAPRIDE patients where ENTERITIS is a reported side effect: 2.9412%

FDA reports of any drug causing ENTERITIS : 1370
Average percentage for all medicated patients where ENTERITIS is reported as a complication: 0.0086%

Physician opinion on ALIZAPRIDE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALIZAPRIDE:
DRUG USE FOR UNKNOWN INDICATION ( 14 patients )
NAUSEA ( 14 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 3 patients )
PREMEDICATION ( 2 patients )
VOMITING ( 2 patients )
ANTIEMETIC SUPPORTIVE CARE ( 2 patients )
PROPHYLAXIS ( 1 patients )
PROPHYLAXIS OF NAUSEA AND VOMITING ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with ENTERITIS:

ACCUTANE (197 patients)
ASPIRIN (124 patients)
FLUOROURACIL (116 patients)
REMICADE (109 patients)
CAPECITABINE (106 patients)
OXALIPLATIN (104 patients)
PREDNISOLONE (103 patients)
CYCLOPHOSPHAMIDE (89 patients)
ZOMETA (85 patients)
PREDNISONE (84 patients)
METHOTREXATE (78 patients)
HUMIRA (77 patients)
PRILOSEC (73 patients)
TACROLIMUS (73 patients)
CISPLATIN (73 patients)
VICODIN (72 patients)
COMPAZINE (69 patients)
LISINOPRIL (67 patients)
AVASTIN (65 patients)
AMBIEN (65 patients)
LASIX (64 patients)
ZOFRAN (61 patients)
BEVACIZUMAB (57 patients)
OMEPRAZOLE (56 patients)
NEXIUM (55 patients)
IBUPROFEN (54 patients)
FLONASE (52 patients)
FOSAMAX (52 patients)
PROTONIX (52 patients)
DECADRON (52 patients)
XELODA (51 patients)
DEXAMETHASONE (51 patients)
ZOCOR (51 patients)
VANCOMYCIN (50 patients)
ALLOPURINOL (50 patients)
AVELOX (49 patients)
AREDIA (49 patients)
PERCOCET (48 patients)
ETOPOSIDE (47 patients)
DOCETAXEL (47 patients)
ENBREL (47 patients)
COREG (45 patients)
PRAVACHOL (45 patients)
ATIVAN (45 patients)
LORAZEPAM (44 patients)
LYRICA (44 patients)
IMODIUM (43 patients)
CETUXIMAB (43 patients)
XANAX (42 patients)
FLAGYL (41 patients)
LEUCOVORIN CALCIUM (41 patients)
TRASTUZUMAB (41 patients)
MEDROL (40 patients)
FOLIC ACID (40 patients)
KEFLEX (40 patients)
CYTOXAN (39 patients)
LEVAQUIN (39 patients)
LIPITOR (39 patients)
ASACOL (39 patients)
ALBUTEROL (37 patients)
ZOLOFT (36 patients)
CLINDAMYCIN (35 patients)
PROZAC (35 patients)
IMURAN (34 patients)
SINGULAIR (34 patients)
FLEXERIL (34 patients)
CERTICAN (34 patients)
AMLODIPINE (34 patients)
EVISTA (34 patients)
LUPRON (33 patients)
DIFLUCAN (33 patients)
CIPROFLOXACIN (33 patients)
FORTEO (32 patients)
OXYCODONE HCL (32 patients)
ROCEPHIN (31 patients)
VELCADE (31 patients)
LOMOTIL (31 patients)
BONIVA (31 patients)
ZYVOX (31 patients)
CARAFATE (30 patients)
PROGRAF (30 patients)
MOBIC (30 patients)
TAGAMET (30 patients)
DILAUDID (30 patients)
BEXTRA (29 patients)
RADIATION THERAPY (29 patients)
ACTOS (29 patients)
AGRYLIN (29 patients)
PERIDEX (29 patients)
EPIRUBICIN (29 patients)
EFFEXOR (28 patients)
INVANZ (28 patients)
PROVIGIL (28 patients)
SALAGEN (28 patients)
PLAQUENIL (28 patients)
CEFTIN (28 patients)
BELLERGAL (28 patients)
MULTI-VITAMINS (28 patients)
ANAGRELIDE HCL (28 patients)
KEFZOL (28 patients)
MEPRON (28 patients)
DONNATAL (28 patients)
CALCIUM CITRATE (28 patients)
DARBEPOETIN ALFA (27 patients)
WELCHOL (27 patients)
CLEOCIN (27 patients)
DIPRIVAN (27 patients)
GAMIMUNE (27 patients)
MEFOXIN (27 patients)
SOL MEDROL (27 patients)
LEVOTHYROXINE SODIUM (27 patients)
LIDODERM (27 patients)
PRANDIN ^KUHN^ (27 patients)
REGELAN (27 patients)
PREVACID (27 patients)
MYCOSTATIN (27 patients)
REVLIMID (27 patients)
FUROSEMIDE (26 patients)
VITAMIN D (26 patients)
METOCLOPRAMIDE (26 patients)
ACETAMINOPHEN (25 patients)
VINCRISTINE (25 patients)
FLOVENT (25 patients)
LANTUS (25 patients)
ATENOLOL (25 patients)
BACTROBAN /NET/ (24 patients)
EXFORGE (VALSARTAN/AMLODIPINE BESILATE) (24 patients)
VIOXX (24 patients)
ACETAMINOPHEN AND CODEINE PHOSPHATE (24 patients)
PAXIL (24 patients)
METOPROLOL TARTRATE (24 patients)
NEPHRO-VITE (24 patients)
BEROCCA /SCH/ (24 patients)
IRINOTECAN HCL (24 patients)
SUDAFED 12 HOUR (24 patients)
SPECTAZOLE (24 patients)
CALCIUM (23 patients)
TRAMADOL HCL (23 patients)
OXYCONTIN (23 patients)
SEROQUEL (23 patients)
PREDNISONE TAB (23 patients)
RITUXIMAB (23 patients)
NIACIN (23 patients)
GABAPENTIN (23 patients)
NIFEDIPINE (22 patients)
AUGMENTIN '125' (22 patients)
TAXOTERE (22 patients)
AMANTADINE HCL (22 patients)
CYCLOSPORINE (22 patients)
CALCITONIN (22 patients)
RIBAVIRIN (22 patients)
DOXYCYCLINE (21 patients)
CORTISONE (21 patients)
ONDANSETRON (21 patients)
AMLODIPINE BESYLATE (21 patients)
DEMEROL (21 patients)
DIOVAN (20 patients)
DARVOCET-N 100 (20 patients)
FAMVIR /NET/ (20 patients)
VITAMIN E (20 patients)
ACYCLOVIR (20 patients)
VITAPLEX (20 patients)
PROSCAR (20 patients)
ALENDRONATE SODIUM (20 patients)
SERZONE (20 patients)
NEUPOGEN (20 patients)
PROCHLORPERAZINE (20 patients)
DICLOFENAC SODIUM (20 patients)
BURINEX (20 patients)
SODIUM CHLORIDE (19 patients)
CARBOPLATIN (19 patients)
LEXAPRO (19 patients)
CASODEX (19 patients)
MYCOPHENOLATE MOFETIL (19 patients)
POLYGAM S/D (19 patients)
MAGNESIUM OXIDE (19 patients)
VITAMIN B-12 (19 patients)
HYZAAR (18 patients)
HYDROCHLOROTHIAZIDE (18 patients)
LANSOPRAZOLE (18 patients)
CELLCEPT (18 patients)
DEMULEN 1/35-28 (18 patients)
LAPATINIB (18 patients)
BENADRYL (18 patients)
METFORMIN HCL (18 patients)
CLONIDINE (18 patients)
WELLBUTRIN (17 patients)
DEPAKOTE (17 patients)
LACTULOSE (17 patients)
RENAGEL (17 patients)
COUMADIN (17 patients)
AMOXICILLIN (17 patients)
AROMASIN (17 patients)
DOXORUBICIN HCL (17 patients)
SUNITINIB MALATE (16 patients)
NORVASC (16 patients)
TRAZODONE HCL (16 patients)
ORTHO TRI-CYCLEN (16 patients)
FLORINEF (16 patients)
COLACE (16 patients)
MIDODRINE HYDROCHLORIDE (16 patients)
CELEBREX (16 patients)
SPIRONOLACTONE (16 patients)
DURAGESIC-100 (15 patients)
PLAVIX (15 patients)
IMIPRAMINE (15 patients)
OMEPRAL (15 patients)
PENTASA (15 patients)
MUCOSTA (15 patients)
PROVERA (15 patients)
Most common side effects for patients taking ALIZAPRIDE:
DIARRHOEA (16 patients)
PYREXIA (16 patients)
VOMITING (10 patients)
FATIGUE (9 patients)
HYPOKALAEMIA (9 patients)
DEHYDRATION (8 patients)
NAUSEA (7 patients)
ANAEMIA (6 patients)
ASTHENIA (6 patients)
BRONCHOPNEUMONIA (6 patients)
DRUG INTERACTION (6 patients)
DYSPNOEA (6 patients)
HYPOTENSION (6 patients)
PNEUMONIA (6 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (5 patients)
HAEMORRHAGE (5 patients)
HYPOMAGNESAEMIA (5 patients)
HYPOPHOSPHATAEMIA (5 patients)
JAUNDICE (5 patients)
RESPIRATORY FAILURE (5 patients)
SOMNOLENCE (5 patients)
TACHYCARDIA (5 patients)
ABDOMINAL PAIN (4 patients)
ADVERSE DRUG REACTION (4 patients)
FALL (4 patients)
HAEMODIALYSIS (4 patients)
HAEMOGLOBIN DECREASED (4 patients)
INTESTINAL OBSTRUCTION (4 patients)
MALAISE (4 patients)
SLEEP APNOEA SYNDROME (4 patients)
SUPRAVENTRICULAR TACHYCARDIA (4 patients)
THROMBOCYTHAEMIA (4 patients)
THROMBOCYTOPENIA (4 patients)
WHITE BLOOD CELL COUNT DECREASED (4 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (3 patients)
BACTERIAL SEPSIS (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
BLOOD CREATININE INCREASED (3 patients)
DECREASED APPETITE (3 patients)
DERMATITIS EXFOLIATIVE (3 patients)
DEVICE DISLOCATION (3 patients)
ENTERITIS (3 patients)
FEBRILE NEUTROPENIA (3 patients)
FIBRIN D DIMER INCREASED (3 patients)
FUSOBACTERIUM INFECTION (3 patients)
HAEMOPTYSIS (3 patients)
HYPOXIA (3 patients)
ILEUS (3 patients)
LEUKAEMIA RECURRENT (3 patients)
MUCOSAL INFLAMMATION (3 patients)
NEUROTOXICITY (3 patients)
NEUTROPENIA (3 patients)
OVERDOSE (3 patients)
PRESYNCOPE (3 patients)
PROTEUS INFECTION (3 patients)
RASH (3 patients)
RENAL FAILURE ACUTE (3 patients)
SEPTIC SHOCK (3 patients)
SUPERINFECTION (3 patients)
TONGUE DISORDER (3 patients)
ACUTE PULMONARY OEDEMA (2 patients)
AGRANULOCYTOSIS (2 patients)
ATRIAL FIBRILLATION (2 patients)
BLOOD FIBRINOGEN INCREASED (2 patients)
BLOOD GLUCOSE INCREASED (2 patients)
BONE MARROW DEPRESSION (2 patients)
BONE MARROW FAILURE (2 patients)
BRONCHOPULMONARY ASPERGILLOSIS (2 patients)
C-REACTIVE PROTEIN INCREASED (2 patients)
CHILLS (2 patients)
COLITIS ISCHAEMIC (2 patients)
CONSTIPATION (2 patients)
CONVULSION (2 patients)
CORONARY ARTERY DISEASE (2 patients)
DEAFNESS (2 patients)
DIZZINESS (2 patients)
DRUG ADMINISTRATION ERROR (2 patients)
DYSPHAGIA (2 patients)
DYSURIA (2 patients)
EJECTION FRACTION DECREASED (2 patients)
ERYSIPELAS (2 patients)
FACIAL PALSY (2 patients)
FEBRILE BONE MARROW APLASIA (2 patients)
FLATULENCE (2 patients)
GASTROENTERITIS (2 patients)
HAEMATOCRIT DECREASED (2 patients)
HYPERSENSITIVITY (2 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (2 patients)
INFECTION (2 patients)
KLEBSIELLA SEPSIS (2 patients)
LEUKOPENIA (2 patients)
LYMPHANGITIS (2 patients)
LYMPHOCYTE COUNT INCREASED (2 patients)
NERVOUS SYSTEM DISORDER (2 patients)
NEUTROPHIL COUNT DECREASED (2 patients)
OEDEMA MUCOSAL (2 patients)
OTITIS MEDIA (2 patients)
PANCYTOPENIA (2 patients)
PARTIAL SEIZURES (2 patients)
PLATELET COUNT DECREASED (2 patients)
PULMONARY EMBOLISM (2 patients)
RED BLOOD CELL COUNT DECREASED (2 patients)
RENAL FAILURE (2 patients)
RHINORRHOEA (2 patients)
SHOCK (2 patients)
STREPTOCOCCAL SEPSIS (2 patients)
SUDDEN CARDIAC DEATH (2 patients)
URTICARIA (2 patients)
ACCIDENTAL OVERDOSE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN (1 patients)
AGITATION (1 patients)
ALVEOLITIS (1 patients)
ANOREXIA (1 patients)
ANXIETY (1 patients)
APHASIA (1 patients)
APHTHOUS STOMATITIS (1 patients)
ARACHNOIDITIS (1 patients)
BLOOD CULTURE POSITIVE (1 patients)
CALCULUS URINARY (1 patients)
CANDIDA SEPSIS (1 patients)
CANDIDIASIS (1 patients)
CARDIO-RESPIRATORY ARREST (1 patients)
CENTRAL NERVOUS SYSTEM LEUKAEMIA (1 patients)
CEREBRAL HAEMORRHAGE (1 patients)
CHEST PAIN (1 patients)
COLITIS (1 patients)
CONFUSIONAL STATE (1 patients)
COUGH (1 patients)
CYANOSIS (1 patients)
DIARRHOEA INFECTIOUS (1 patients)
DISEASE PROGRESSION (1 patients)
DISLOCATION OF VERTEBRA (1 patients)
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG (1 patients)
DRUG HYPERSENSITIVITY (1 patients)
DRUG TOXICITY (1 patients)
DRY SKIN (1 patients)
ENCEPHALOPATHY (1 patients)
EPILEPSY (1 patients)
ERYTHEMA (1 patients)
FLUSHING (1 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (1 patients)
GENERAL PHYSICAL CONDITION ABNORMAL (1 patients)
GRAFT VERSUS HOST DISEASE (1 patients)
HAEMATURIA (1 patients)
HEADACHE (1 patients)
HYPERBILIRUBINAEMIA (1 patients)
HYPERTENSIVE CRISIS (1 patients)
HYPOACUSIS (1 patients)
HYPOAESTHESIA (1 patients)
HYPOCALCAEMIA (1 patients)
HYPOMANIA (1 patients)
HYPOVOLAEMIC SHOCK (1 patients)
KLEBSIELLA INFECTION (1 patients)
LACTOSE INTOLERANCE (1 patients)
LEUKAEMIA PLASMACYTIC (1 patients)
METASTATIC NEOPLASM (1 patients)
MULTI-ORGAN FAILURE (1 patients)
MULTIPLE MYELOMA (1 patients)
MUSCULAR WEAKNESS (1 patients)
MYALGIA (1 patients)
MYOGLOBIN BLOOD INCREASED (1 patients)
NEOPLASM (1 patients)
NEURALGIA (1 patients)
OEDEMA (1 patients)
OEDEMA PERIPHERAL (1 patients)
PAIN (1 patients)
PARESIS (1 patients)
PNEUMONIA KLEBSIELLA (1 patients)
PNEUMONITIS (1 patients)
PRODUCTIVE COUGH (1 patients)
PRURITUS (1 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (1 patients)
PULMONARY HYPERTENSION (1 patients)
RADIUS FRACTURE (1 patients)
RASH GENERALISED (1 patients)
RASH MACULAR (1 patients)
RASH MACULO-PAPULAR (1 patients)
RENAL COLIC (1 patients)
RESPIRATORY DISTRESS (1 patients)
RIGHT VENTRICULAR DYSFUNCTION (1 patients)
SEPSIS (1 patients)
SKIN LESION (1 patients)
SPUTUM PURULENT (1 patients)
STAPHYLOCOCCAL BACTERAEMIA (1 patients)
STEM CELL TRANSPLANT (1 patients)
STOMATITIS (1 patients)
THROMBOSIS (1 patients)
THROMBOTIC MICROANGIOPATHY (1 patients)
TOXICITY TO VARIOUS AGENTS (1 patients)
ULNA FRACTURE (1 patients)
WEIGHT DECREASED (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALIZAPRIDE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about ENTERITIS and ALIZAPRIDE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALIZAPRIDE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALIZAPRIDE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALIZAPRIDE experts. If you are a healthcare provider experienced in prescribing ALIZAPRIDE, please register here.

Your online appointment book for Nashville Rentals & Services

Chef and Catering services in Nashville
Chiropracter and Massage services in Nashville
Event and Wedding Planning services in Nashville
Hair Styling services in Nashville
Personal Shopping services in Nashville
Photography and Videography services in Nashville
Private Investigation services in Nashville
Website Design services in Nashville

Home
Appliance Repair services in Nashville
Appraisals services in Nashville
Awnings services in Nashville
Builder Services services in Nashville
Carpentry services in Nashville
Cleaning services in Nashville
Decks and Porches services in Nashville
Electricians services in Nashville
Fireplace services in Nashville
Generators services in Nashville
Greenhouses and Nurseries services in Nashville
Handymen services in Nashville
Home Security services in Nashville
HVAC services in Nashville
Insulation services in Nashville
Interior Design services in Nashville
Landscaping services in Nashville
Lawn and Yard services in Nashville
Locksmiths services in Nashville
Marble and Granite Experts services in Nashville
Masonry services in Nashville
Moving Services services in Nashville
Painters services in Nashville
Plumbing services in Nashville
Pool and Spa services in Nashville
Property Management services in Nashville
Roofers services in Nashville
Snow Plowing services in Nashville
Solar Power Consultants services in Nashville
Upholstery services in Nashville
Wallpaper services in Nashville
Waterproofing services in Nashville
Windows services in Nashville
Services - Other

© 2014 FactMed, Inc
Privacy Policy
Terms of Use